Physician profile

Matthew William Segar

Internal Medicine · Houston, TX

NPI 1942703749

$47,235.76

in general payments reported to CMS, 2019-2025

41 companies · $7,224 in 2025

The $7,224 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).

See the full distribution for Internal Medicine

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$10,159.36
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$7,490.00
Grant$4,500.00
Travel and Lodging$3,460.24
Education$812.15

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $18,354.18 2022
Medtronic, INC. $10,012.35 2021-2025 Micra, Na, Cobalt Dr Mri Surescan
Idorsia Pharmaceuticals US INC $6,916.39 2024 Tryvio
Biosense Webster, INC. $3,133.50 2023-2025 Carto 3
Boston Scientific Corporation $1,630.65 2023-2025 Watchman Access System, Watchman Flx, Watchman
Abbott Laboratories $1,084.40 2023-2025 Assurity, Ensite, Aveir
Otsuka Pharmaceutical Co., LTD. $1,050.00 2025 Samsca
Medical Device Business Services, INC. $1,031.97 2021-2023 Carto 3
Actelion Pharmaceuticals US, INC. $541.88 2021-2025 Opsumit, Uptravi
Impulse Dynamics (USA) INC. $531.51 2022-2024 Optimizer, Optimizer
Pfizer INC. $363.18 2021-2024
Novartis Pharmaceuticals Corporation $328.47 2021-2025
Amgen INC. $308.37 2022-2025 Repatha
Inari Medical, INC. $252.86 2021-2023 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Sanofi-Aventis U.S. LLC $250.66 2022-2023
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Cardiva Medical, INC. $155.29 2023-2024 Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs
Astrazeneca Pharmaceuticals LP $152.80 2021-2025 Wainua, Farxiga
Atricure, INC. $127.71 2024
Chiesi USA, INC. $113.94 2021-2022
Astellas Pharma US INC $101.07 2021
Janssen Pharmaceuticals, INC $83.23 2022-2024 Xarelto
Shockwave Medical, INC $74.59 2022-2023 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
W. L. Gore & Associates, INC. $71.06 2021-2023 Gore Cardioform Septal Occluder
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $58.50 2024-2025 Lifevest
Cvrx, INC. $57.17 2024-2025 Barostim Neo System
Novo Nordisk INC $48.71 2023 Ozempic
Kiniksa Pharmaceuticals International, Plc $46.71 2024 Arcalyst
Bridgebio Pharma, INC. $42.05 2025 Attruby
Kiniksa Pharmaceuticals, LTD. $39.98 2023 Arcalyst
Procyrion, INC. $38.94 2024
Bayer Healthcare Pharmaceuticals INC. $26.88 2022
Abiomed $25.70 2025
Baxter Healthcare $24.83 2025 Hillrom - Carnation Ambulatory Monitor
Cordis US Corp. $24.37 2023 Outback Elite
Boehringer Ingelheim Pharmaceuticals, INC. $23.52 2024 Jardiance
Bard Peripheral Vascular, INC. $21.13 2023 Lutonix Drug Coated Balloon
Medline Industries LP $18.95 2024 Medline Industries, INC.
Vifor Pharma, INC. $18.61 2021
Contego Medical, INC $18.49 2024
Heartflow, INC. $17.12 2024
E.R. Squibb & Sons, L.L.C. $14.04 2023 Eliquis

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$4,900.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Matthew William Segar

$47,235.76

in general payments reported 2019-2025

Years
2021-2025
Top company
Merck Sharp & Dohme LLC
Context
The $7,224 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/7646022/matthew-william-segar

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.